Catalyst Biosciences Inc (NASDAQ:CBIO)
| 6.86 Delayed Data As of Jan 22 |  +0.20 / +3.00%Today’s Change | 3.43 Today|||52-Week Range 8.94 | +8.72% Year-to-Date |
Latest CBIO News | Press Releases
No recent news for Catalyst Biosciences Inc.
Today’s Trading
| Previous close | 6.66 |
| Today’s open | 6.63 |
| Day’s range | 6.63 - 6.89 |
| Volume | 3,636 |
| Average volume (3 months) | 263,367 |
| Market cap | $142.1M |
Data as of 3:59pm ET, 01/22/2021
Growth & Valuation
| Earnings growth (last year) | -71.49% |
| Earnings growth (this year) | +46.20% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.13 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LJPCLa Jolla Pharmaceuti... | 0.00 | 0.00% |
| PLXProtalix Biotherapeu... | +0.00 | +0.11% |
| IFRXInflarx NV | +0.05 | +0.89% |
| EQEquillium Inc | +0.29 | +5.07% |
Data as of 3:59pm ET, 01/22/2021
Financials
| Next reporting date | March 11, 2021 |
| EPS forecast (this quarter) | -$0.78 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$55.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
